Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$43.91 +1.86 (+4.42%)
At close: Nov 10, 2026 · 4:00 PM EST

Rigel Pharmaceuticals (RIGL) Capital Leases (2010)

Updated

Rigel Pharmaceuticals (RIGL) recorded Capital Leases of $45,000 in Q4 2010.

Analysis

Rigel Pharmaceuticals (RIGL) Capital Leases (2010) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Rigel Pharmaceuticals 801.35 Mn 305.08 Mn 70.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 45,000.00
API Access

Rigel Pharmaceuticals Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=RIGL&period=max&api_key=YOUR_API_KEY